首页 | 本学科首页   官方微博 | 高级检索  
     


Ionizing radiation biomarkers for potential use in epidemiological studies
Authors:Pernot Eileen  Hall Janet  Baatout Sarah  Benotmane Mohammed Abderrafi  Blanchardon Eric  Bouffler Simon  El Saghire Houssein  Gomolka Maria  Guertler Anne  Harms-Ringdahl Mats  Jeggo Penny  Kreuzer Michaela  Laurier Dominique  Lindholm Carita  Mkacher Radhia  Quintens Roel  Rothkamm Kai  Sabatier Laure  Tapio Soile  de Vathaire Florent  Cardis Elisabeth
Affiliation:Barcelona Biomedical Research Park, Doctor Aiguader, Barcelona, Spain. epernot@creal.cat
Abstract:Ionizing radiation is a known human carcinogen that can induce a variety of biological effects depending on the physical nature, duration, doses and dose-rates of exposure. However, the magnitude of health risks at low doses and dose-rates (below 100mSv and/or 0.1mSvmin(-1)) remains controversial due to a lack of direct human evidence. It is anticipated that significant insights will emerge from the integration of epidemiological and biological research, made possible by molecular epidemiology studies incorporating biomarkers and bioassays. A number of these have been used to investigate exposure, effects and susceptibility to ionizing radiation, albeit often at higher doses and dose rates, with each reflecting time-limited cellular or physiological alterations. This review summarises the multidisciplinary work undertaken in the framework of the European project DoReMi (Low Dose Research towards Multidisciplinary Integration) to identify the most appropriate biomarkers for use in population studies. In addition to logistical and ethical considerations for conducting large-scale epidemiological studies, we discuss the relevance of their use for assessing the effects of low dose ionizing radiation exposure at the cellular and physiological level. We also propose a temporal classification of biomarkers that may be relevant for molecular epidemiology studies which need to take into account the time elapsed since exposure. Finally, the integration of biology with epidemiology requires careful planning and enhanced discussions between the epidemiology, biology and dosimetry communities in order to determine the most important questions to be addressed in light of pragmatic considerations including the appropriate population to be investigated (occupationally, environmentally or medically exposed), and study design. The consideration of the logistics of biological sample collection, processing and storing and the choice of biomarker or bioassay, as well as awareness of potential confounding factors, are also essential.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号